2018
DOI: 10.1080/1354750x.2018.1443511
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic and diagnostic value of elevated serum concentration of procalcitonin in patients with suspected heart failure. A review and meta-analysis

Abstract: In patients with HF, an elevated serum PCT concentration predicted the short-term risk of death.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…26 Elevated serum PCT levels predict the risk of short-term mortality in patients with heart failure. 27 In addition, PCT levels are superior to CRP levels and pro-adrenomedullin (MR-proADM) levels for predicting adverse cardiovascular events and all-cause mortality in patients with type 2 diabetes. 28 Recent studies have suggested that PCT is an independent marker of fat accumulation and metabolic parameters associated with obesity status.…”
Section: Discussionmentioning
confidence: 99%
“…26 Elevated serum PCT levels predict the risk of short-term mortality in patients with heart failure. 27 In addition, PCT levels are superior to CRP levels and pro-adrenomedullin (MR-proADM) levels for predicting adverse cardiovascular events and all-cause mortality in patients with type 2 diabetes. 28 Recent studies have suggested that PCT is an independent marker of fat accumulation and metabolic parameters associated with obesity status.…”
Section: Discussionmentioning
confidence: 99%
“…A recent longitudinal analysis of 86,000 individuals with incident HF also specifically identified infections as an important opportunity to positively impact HF prognosis [9]. The prevention of hospital-acquired infections, early detection of infection using procalcitonin, early initiation of optimal antibiotics, and adequate duration of therapy may prevent and reduce risk of hospital readmissions in patients with HF [14,16,24,25]. The data for procalcitonin for guiding antibiotic decision making remains mixed, but has been more consistently shown to aid in antibiotic de-escalation or discontinuation [26,27].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the characterization of the type of infections that affect patients hospitalized for HF is limited. Describing the epidemiology of infectious complications, especially bacterial infections, and their impact on outcomes is important to understanding how this comorbidity could be targeted to further improve HF outcomes [14]. This study aims to describe the epidemiology of acute infections, specifically bacterial pathogens, as these represent the most common etiology for infected patients hospitalized for HF [15,16], and to evaluate their associations to longitudinal HF outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…The rationale to choose NLR and PLR was based on the promising results in other settings 11 , 12 . PCT was chosen to include one established marker of systemic inflammation as comparison that may also be useful in patients with cardiac disease 15 . All markers were measured within 24 h after VA-ECMO initiation.…”
Section: Methodsmentioning
confidence: 99%